Eli Lilly now offers higher-dose Zepbound online for $499 monthly, with no insurance needed.

Eli Lilly sues four companies for selling unapproved versions of its weight-loss drug tirzepatide, citing safety concerns and illegal practices.

Eli Lilly's weight-loss drug Mounjaro sees soaring demand in India after local launch, with clinics reporting hundreds of patient inquiries.

Eli Lilly's orforglipron, a once-daily pill, could transform the weight loss drug market with its needle-free convenience and potential market dominance.

Eli Lilly invests $27 billion in U.S. manufacturing to boost drug production and strengthen the supply chain.

Eli Lilly is suing medical spas and vendors for selling unapproved, fake weight-loss products containing their active ingredient, tirzepatide.

A new study reveals that semaglutide, a key ingredient in Ozempic and Wegovy, reduces the risk of dying from Covid-19 by 33%, [otentially boosting its market value.

Eli Lilly is launching a lower-priced version of its weight loss drug Zepbound to increase access and combat counterfeit versions.

Shares of pharmaceutical companies Novo Nordisk and Eli Lilly slid after Roche announced results from a promising early-stage trial for its proposed obesity drug.

President Joe Biden and Senator Bernie Sanders have urged Novo Nordisk and Eli Lilly to lower the prices of their popular weight loss drugs.